RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,000 | -33.3% | 584 | -46.5% | 0.00% | – |
| Q2 2023 | $3,000 | 0.0% | 1,092 | -32.7% | 0.00% | – |
| Q1 2023 | $3,000 | -91.7% | 1,622 | -84.2% | 0.00% | – |
| Q4 2022 | $36,000 | -85.4% | 10,291 | +54.6% | 0.00% | – |
| Q3 2022 | $246,000 | +100.0% | 6,658 | +2.7% | 0.00% | – |
| Q2 2022 | $123,000 | -42.0% | 6,484 | -17.5% | 0.00% | – |
| Q1 2022 | $212,000 | -1.4% | 7,856 | -17.6% | 0.00% | – |
| Q4 2021 | $215,000 | -16.3% | 9,537 | -2.8% | 0.00% | – |
| Q3 2021 | $257,000 | -15.7% | 9,811 | +3.0% | 0.00% | – |
| Q2 2021 | $305,000 | -6.4% | 9,527 | +2.7% | 0.00% | – |
| Q1 2021 | $326,000 | -58.4% | 9,277 | -62.0% | 0.00% | – |
| Q4 2020 | $783,000 | -14.8% | 24,399 | -0.1% | 0.00% | – |
| Q3 2020 | $919,000 | +91800.0% | 24,426 | +93846.2% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 26 | -27.8% | 0.00% | – |
| Q4 2019 | $1,000 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |